OTA Sources Sought - Asbestos Related Disease Screening - Libby, MT

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

CDC OFFICE OF ACQUISITION SERVICES

Contract Value

Not provided

Codes & Classification
Solicitation Number

CDC-OTA-SSN-26-0001

NAICS

621511 - Medical Laboratories

Classification Code

Q999

Additional Details
Set Aside

NONE

Place of Performance

Libby, Montana, UNITED STATES

SourceSAM
Documents2
The Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services, has issued a Special Notice seeking sources for an upcoming opportunity related to asbestos-related disease (ARD) screening in Libby, Montana. This notice, identified as CDC-OTA-SSN-26-0001, is a request for information (RFI) and not a solicitation; its purpose is to gather input from the commercial marketplace to inform the agency’s understanding of available capabilities and to refine program objectives. A formal solicitation is anticipated to be released later in Fiscal Year 2026. The CDC intends to utilize its Other Transaction Authority (OTA) for this procurement, which allows for flexible, innovative approaches to addressing complex public health challenges. The overarching goal of this initiative is to modernize and renew the long-term screening and outreach strategy for asbestos-related diseases in the Libby community, leveraging predictive modeling and advanced data analytics. The program is structured around three primary components: 1. **Screening and Outreach:** The selected partner will be responsible for providing annual health screenings for asbestos-related diseases such as pleural plaque, asbestosis, lung cancer, and mesothelioma, as well as other associated conditions. This component also includes conducting education and awareness campaigns to ensure eligible individuals are informed and supported in seeking care. 2. **Technological Innovation:** The CDC seeks to identify, test, and integrate new diagnostic tools, digital health platforms, or data-sharing technologies that can enhance the accuracy and efficiency of ARD detection. This focus on innovation is intended to ensure the program remains at the forefront of medical and technological advancements. 3. **Strategic Research and Community Legacy:** The program will involve analyzing demographic and exposure data to forecast future screening needs and developing data-driven triggers and timelines for the program’s evolution. Additionally, the strategy should support the sustainability of local healthcare infrastructure, ensuring that services for impacted residents are integrated and maintained over the long term. The place of performance for this opportunity is Libby, Montana. The applicable NAICS code is 621511 (Medical Laboratories), and the Product Service Code is Q999. There are no set-aside requirements for this procurement, making it open to all qualified entities. Interested parties are encouraged to review the attached OTA Sources Sought and Draft Statement of Objectives for further details. For clarifying questions, respondents must contact both Ted Larson, Lead Epidemiologist ([email protected]), and Emilio Cibula, Agreements Officer ([email protected]). This notice is issued by the CDC Office of Acquisition Services. The response deadline for this RFI is September 7, 2026, at 3:07 PM. Contractors with expertise in medical laboratory services, public health outreach, technological innovation in diagnostics, and community health infrastructure are encouraged to consider this opportunity and provide input to help shape the forthcoming solicitation. For more information and to access the attachments, please refer to the official notice on SAM.gov at: https://sam.gov/opp/524d0d03dd1a4cd49940a201c35698fb/view.